WILLIAM J. CHASE - 14 Apr 2023 Form 3 Insider Report for Intellia Therapeutics, Inc. (NTLA)

Role
Director
Signature
/s/ James Basta, Attorney-in-fact
Issuer symbol
NTLA
Transactions as of
14 Apr 2023
Net transactions value
$0
Form type
3
Filing time
18 Apr 2023, 16:49:52 UTC
Next filing
16 Jun 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding NTLA Common Stock 6,800 14 Apr 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Exhibit 24.1 - Power of Attorney